Close Menu

NEW YORK – Startup 54gene, which plans to focus on genomics of Africans, said this week that it has raised $4.5 million in seed funding.

Investors in the firm include Y Combinator, Fifty Years, Better Ventures, KdT Ventures, Hack VC, Pioneer Fund, and Techammer.

The company, founded earlier this year and based in San Francisco and in Lagos, Nigeria, plans to address the fact that only 2 percent of human DNA samples used in pharmaceutical research today are from Africans or those of African ancestry, who have much greater genetic diversity than other human populations.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Retraction Watch reports that a paper was pulled because it refers to a gene that doesn't exist in mice.

Researchers were able to generate fertilized northern white rhinoceros eggs, according to Mashable.

Former Orig3n employees raise concerns about its testing at Bloomberg Businessweek.

In PLOS this week: microRNA expression changes in hepatocellular carcinoma, real-time PCR-based approach for diagnosing schistosomiasis, and more.